Refine by
Disease Progression Equipment & Supplies
98 equipment items found
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1602 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
At BioArctic, research is in progress to develop new antibodies for the treatment of Alzheimer’s disease aimed at slowing down or stopping disease progression by addressing novel ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1601 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:Ampersand Biosciences based inLake Clear, NEW YORK (USA)
Chromogranin B (CgB) aka Secretogranin-1, Uniprot # P05060, is an acidic member of the granin family found in a variety of neurons and endocrine cells. CgB is a marker in neuroendocrine tumors with plasma levels potentially being associated with disease ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The drug candidate ABBV-0805 is a monoclonal antibody that selectively binds and eliminates oligomers and protofibrils of alpha-synuclein. The goal is to develop a disease modifying treatment that stops or slows down disease ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso2 is a preclinical program targeting Crohn’s disease. It aims to develop Christensenella gut bacteria as a safe, efficient and groundbreaking oral biotherapy. YSOPIA has identified a lead candidate to relieve Crohn’s disease associated symptoms and slow down disease progression. ...
Manufactured by:Aison Technologies based inSchlieren, SWITZERLAND
Surrogate parameter for rheumatoid arthritis diagnosis. Reduce need for expensive MRI scans. Disease progression monitoring in drug development and research. Save time, reduce costs and increase ...
Manufactured by:JD Bioscience Inc. (JDB) based inBuk-gu, SOUTH KOREA
NASH, an advanced form of non-alcoholic fatty liver disease (NAFLD), can progress to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Genetic factors, environmental factors, and microbiome alterations are mainly involved in disease progression. Experts estimated that 24% of U.S. adults have NAFLD and more than 6.5% ...
by:Numares GROUP Corp based inRegensburg, GERMANY
Common cancers with established benefit of early diagnosis but for which there are no sensitive or specific tests are prostate, bladder and liver cancer1. Expensive imaging procedures are routinely required in clinical practice for diagnosis or to monitor disease progression of these cancers. To date, there are no accurate biomarkers for either diagnosis or ...
by:AdAlta Limited based inBundoora, AUSTRALIA
A specific form of lung fibrosis is Idiopathic pulmonary fibrosis (IPF), which is a chronic and ultimately fatal disease, where tissue deep in the lungs becomes scarred, over time, resulting in a progressive decline in lung function and shortness of breath. There is currently no cure for IPF with most people living only three to five years after diagnosis. The ...
Manufactured by:DxTerity Diagnostics Inc. based inRancho Dominguez, CALIFORNIA (USA)
DxTerity’s IFN-1 Test uses a simple fingerstick blood collection conducted at your doctor's office. Measure your IFN-1 levels and know your risks for SLE disease progression. Take back control of your ...
Manufactured by:Microbiotica Limited based inLittle Chesterford, UNITED KINGDOM
Microbiotica accesses high quality large-scale clinical datasets in order to identify microbiome-based biomarkers of drug response, drug side-effects or disease progression. The company has accessed the clinical data from academic/clinical collaborations (University of Adelaide, Cambridge University Hospitals/Cancer Research UK) or from pharma partners ...
Manufactured by:United Therapeutics Corporation based inSilver Spring, MARYLAND (USA)
Orenitram is a prostacyclin mimetic indicated for treatment of pulmonary arterial hypertension (PAH; WHO Group 1), to delay disease progression and to improve exercise capacity. The studies that established effectiveness included predominately patients with WHO functional class II-III symptoms and etiologies of idiopathic or heritable PAH (66%) or PAH associated ...
Manufactured by:Ncardia Services B.V. based inLeiden, NETHERLANDS
Astrocytes are essential players in neurodegenerative disease progression providing a valuable tool for drug discovery and disease modeling. Human iPSC-derived astrocytes generated with our standardized process express key identity markers and support co-culture with human iPSC-derived neurons. Our team can manufacture astrocytes at scale ...
by:tiakis BIOTECH AG based inKiel, GERMANY
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression in patients with mild Alzheimer’s disease (AD)[1]. Azeliragon also can cross the blood-brain barrier ...
Manufactured by:Ocugen, Inc. based inMalvern, PENNSYLVANIA (USA)
OCU200 is a biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic Retinopathy (DR), and Wet Age-Related Macular Degeneration (Wet-AMD). Patients affected by these diseases share common symptoms, such as blurriness in vision and progressive vision loss as ...
Manufactured by:Datar Cancer Genetics based inGuildford, UNITED KINGDOM
CTACs include cancer cells that escape from the tumor and enter the bloodstream (circulating tumor cells, CTCs) as well as tumor-associated cells (TACs) which contribute to tumor survival and growth. Chemo-resistance in CTACs may be associated with a risk of treatment failure and disease ...
Manufactured by:GENFIT based inLoos, FRANCE
Nonalcoholic steatohepatitis (NASH) remains largely underdiagnosed, as it carries no obvious symptoms in its early stages, and also because of the lack of widely available non-invasive tests specifically developed to diagnose the disease. The underdiagnosis of NASH represents a major unmet need, and is a barrier for identification of patients at higher risk for ...
Manufactured by:COGNISION based inLouisville, KENTUCKY (USA)
By facilitating an objective evaluation of patients with cognitive disorders, COGNISION® helps neurologists and other physicians differentiate between dementia and depression, track disease progression and assess overall cognitive deficits associated with dementia and concussion/mTBI. ...